%0 Journal Article
%T 生物医学公司融资困境的成因及对策研究&#8212;&#8212;以X生物科技公司为例<br>Research on the Causes and Countermeasures of Financing Difficulties in Biomedical Companies&#8212;Taking X Biotechnology Company as an Example
%A 陆璐
%J E-Commerce Letters
%P 3521-3526
%@ 2168-5851
%D 2024
%I Hans Publishing
%R 10.12677/ecl.2024.1341550
%X 文章围绕生物医学公司面临的融资困境及其成因进行了深入探讨&#65292;并提出了相应的解决对策。文章首先分析了生物医学公司融资现状&#65292;系统地剖析了融资困境的成因。在此基础上&#65292;文章提出了相应的解决对策。旨在通过这些策略的实施&#65292;帮助生物医学公司有效应对融资难题&#65292;为其持续发展提供支撑。<br>This paper delves into the financing challenges faced by biomedical companies and explores the underlying causes. It begins with an analysis of the current state of financing for biomedical companies, systematically examining the factors contributing to these challenges. Based on this analysis, the paper proposes corresponding solutions aimed at helping biomedical companies effectively address their financing difficulties and supporting their sustainable development through the implementation of these strategies.
%K 生物医学公司&#65292
%K 融资困境&#65292
%K 内部管理&#65292
%K 技术转化&#65292
%K 创新能力<br>Biomedical Companies
%K Financing Challenges
%K Internal Management
%K Technology Transfer
%K Innovation Capability
%U http://www.hanspub.org/journal/PaperInformation.aspx?PaperID=100586